Montserrat Montraveta
Barcelona, CT 08916, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy.
Journal: International journal of molecular sciences
Published: February 18, 2025
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Journal: Pharmacological research
Published: March 13, 2023
Successful long-term treatment of paediatric ulcerative colitis with vedolizumab: a case report.
Journal: European journal of hospital pharmacy : science and practice
Published: June 22, 2022
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.
Journal: European journal of pediatrics
Published: May 24, 2021
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.
Journal: European journal of pediatrics
Published: October 17, 2020
HLA-DQ2/DQ8 and HLA-DQB1*02 homozygosity typing by real-time polymerase chain reaction for the assessment of celiac disease genetic risk: evaluation of a Spanish celiac population.
Journal: Tissue antigens
Published: April 28, 2014
Biomarkers for diagnosis and monitoring of celiac disease.
Journal: Journal of clinical gastroenterology
Published: February 08, 2013
Urinary levels of regenerating protein Iα do not differentiate celiac patients and healthy subjects.
Urinary levels of regenerating protein Iα do not differentiate celiac patients and healthy subjects.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: January 15, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026